Aconwell Pharma Private Limited
Aconwell Pharma Private Limited is a Private Non-govt company company incorporated in 2019 and based in Haryana, India. It was founded by Rocky and Jitender. Aconwell Pharma Private Limited operates in Pharmaceuticals & Chemicals (NIC 24290) with authorized capital of ₹10.00 L and paid-up capital of ₹4.00 L. For 2021-22, the company reported revenue of ₹6.15 Cr and profit after tax of ₹7.73 L. RegisterKaro's provisional Compliance Health Score for the company is 67/100 (grade C), based on 4 of 9 signals — full scoring is pending extraction of the company's MCA filing history.
Quick facts
Directors
LockedDirectors, DINs & appointment history for Aconwell Pharma Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
MCA Filings
Locked| Form | FY | Filed | Due | Delay | Status |
|---|---|---|---|---|---|
| AOC-4 | FY2024-25 | 30 Oct 2024 | 30 Oct 2024 | 0d | filed |
| MGT-7 | FY2024-25 | 26 Nov 2024 | 29 Nov 2024 | 0d | filed |
| AOC-4 | FY2023-24 | 30 Oct 2023 | 30 Oct 2023 | +29d | filed |
| MGT-7 | FY2023-24 | 25 Nov 2023 | 29 Nov 2023 | 0d | filed |
| AOC-4 | FY2022-23 | 30 Oct 2022 | 30 Oct 2022 | 0d | filed |
| MGT-7 | FY2022-23 | 24 Nov 2022 | 29 Nov 2022 | 0d | filed |
Full MCA filing history for Aconwell Pharma Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Charges
Locked| Charge ID | Holder | Amount | Created | Status |
|---|---|---|---|---|
| 212410986 | Kotak Mahindra Bank Ltd(Bank) | ₹18.07 Cr | 04 Jul 2020 | Open |
| 703561909 | Axis Bank Ltd(Bank) | ₹7.67 Cr | 19 Sep 2021 | Satisfied |
| 248875916 | HDFC Bank Ltd(Bank) | ₹6.63 Cr | 12 Mar 2019 | Satisfied |
| 215209385 | ICICI Bank Ltd(Bank) | ₹20.58 Cr | 27 Jan 2021 | Open |
| 157719784 | State Bank of India(Bank) | ₹24.45 Cr | 04 Jul 2019 | Satisfied |
Charge IDs, lenders & amounts for Aconwell Pharma Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Financial Performance
MCA| FY | Revenue | PAT | Net Worth | Total Assets | Employees |
|---|---|---|---|---|---|
| 2021-22 | — | ||||
| 2019-20 | — |
Detailed Financials
2 FYs| Line item | 2021-22 | 2019-20 |
|---|---|---|
| Income statement | ||
| Revenue from operations | ||
| Other income | ||
| Total income | ||
| Total expenses | ||
| Profit before tax | ||
| Profit / (Loss) after tax | ||
| Balance sheet | ||
| Equity / Net worth | ||
| Borrowings | ||
| Current liabilities | ||
| Total liabilities | ||
| Current assets | ||
| Cash & equivalents | ||
| Total assets | ||
| Employees | — | — |
Cash-flow statement renders when the AOC-4 XBRL Cash Flow context is parsed during the extract phase.
Compounded Annual Growth Rate
| Metric | Latest value | 1Y CAGR | 3Y CAGR | 5Y CAGR |
|---|---|---|---|---|
| Revenue2021-22 | +193.0% | — | — | |
| Profit after Tax2021-22 | +760.0% | — | — | |
| Net Worth2021-22 | +866.0% | — | — |
Financial Ratios
| FY | Revenue | PAT | PAT margin | Rev growth | ROE | ROA | D/E | Rev/emp |
|---|---|---|---|---|---|---|---|---|
| 2019-20 | +2.26% | — | +37.00% | +4.19% | 8.84 | |||
| 2021-22 | +1.26% | +491.90% | +41.58% | +2.79% | 14.91 |
Cap Table & Shareholding
Locked| Category | Shareholders | Shares held | % |
|---|---|---|---|
| Promoters | 1 | 98,09,112 | 90.10% |
| Institutional Investors | 1 | 3,55,272 | 3.26% |
| Public & Others | 20 | 7,22,895 | 6.64% |
Promoter, institutional & public holding for Aconwell Pharma Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Peer Benchmark
60 peersEvents & timeline
4External data sources
7 plannedGSTIN Registrations
Per-state GSTINs + GSTR-1/3B filing cadence + turnover bracket. PAN-keyed scrape.
MSME Payment Delays
Half-yearly disclosure of payments delayed beyond 45 days to MSME suppliers.
Related Party Transactions
Counterparty, nature, transaction value. Inter-company loans, sales, royalty.
Credit Ratings
Long-term + short-term ratings, with rationale on rating actions.
Trademarks
Applied, registered, opposed. Class numbers + status.
Patents
Applications and grants. Inventor names + filing dates.
Legal Cases
Ongoing + past litigations the entity is party to.
Each source is wired as a separate ingestion adapter behind the scraper. Live status flips per CIN as records land.